Atlas Trials

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Clinical trial NCT07146815 · COMPLETED

Trial details

NCT number
NCT07146815
Sponsor
Ziekenhuis Oost-Limburg
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
NAFLD (Nonalcoholic Fatty Liver Disease)Polycystic Ovarian Syndrome (PCOS)
Start date
2022-11-29
Primary completion
2025-04-01
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.